Letter: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients – authors’ reply

P. Lampertico; T. Berg

doi:10.1111/apt.13733

Letter: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients – authors’ reply

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	538
Number of pages	1
Journal	Alimentary Pharmacology and Therapeutics
Volume	44
Issue number	5
DOIs	https://doi.org/10.1111/apt.13733
Publication status	Published - Sep 1 2016

ASJC Scopus subject areas

Medicine(all)
Pharmacology (medical)

Access to Document

10.1111/apt.13733

Cite this

@article{9a92a1e2d6be485bbfbbac4bc5decf2e,

title = "Letter: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients – authors{\textquoteright} reply",

author = "P. Lampertico and T. Berg",

year = "2016",

month = sep,

day = "1",

doi = "10.1111/apt.13733",

language = "English",

volume = "44",

pages = "538",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Letter

T2 - long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients – authors’ reply

AU - Lampertico, P.

AU - Berg, T.

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84982863350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982863350&partnerID=8YFLogxK

U2 - 10.1111/apt.13733

DO - 10.1111/apt.13733

M3 - Letter

C2 - 27484939

AN - SCOPUS:84982863350

VL - 44

SP - 538

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 5

ER -

Letter: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients – authors’ reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this